Master
Media Component
Heading
Section Highlights
Content
- Section faculty published 194 peer-reviewed articles, including 50 in top-tier journals such as NEJM, Lancet, Nature Medicine, Cell, and JACC, showcasing strength in basic, translational, and clinical cardiovascular research.
- The Center for Cardiometabolic Disease Prevention conducted late-breaking clinical trials with simultaneous publication in the New England Journal of Medicine, advancing therapies in lipid disorders and cardiometabolic disease.
- Dr. Miguel A. Cruz received a competitive NHLBI T32 renewal and a DOD grant, while Dr. Na Li and Dr. Xinchun Pi secured new or renewed NIH R01 funding for projects in cardiac arrhythmias and metabolic signaling.
- The Lipid Metabolism and Atherosclerosis Clinic, led by Drs. Christie Ballantyne and Ron Hoogeveen, is the only program in Houston offering comprehensive genetic testing, including polygenic risk scores, for cardiometabolic conditions.
- Faculty received national recognition and leadership appointments, including Dr. Christie Ballantyne as President of the National Lipid Association and Dr. Na Li as Chair of the Heart Rhythm Society Research Fellowship Committee.
- The Section actively supports trainee development through conferences, research opportunities, and mentorship. Fellows and students earned national awards and fellowships, including recognition from the American Diabetes Association and ACC.
- Among cardiac/cardiovascular programs worldwide, Baylor College of Medicine is ranked #20 for publications, #20 for citations, #26 for number of publications among the 10% most cited, and #32 for number of highly cited papers among the top 1% by U.S. News and World Report
- Expertscape rankings of section faculty include #1 expert in LDL-C in the United States and #3 in the world, and top 0.01% for Atherosclerosis
- Section faculty published ~200 articles this year, 50 in high-impact journals including New England Journal of Medicine, Lancet, Nature Medicine, and Cell
- Section faculty presented basic science, clinical, and translational research at key national and international conferences, including the annual meetings of the American College of Cardiology, American Diabetes Association, and American Heart Association
- The section's Preventive Cardiology fellow was a finalist for the American College of Cardiology Scientific Session Young Investigator Award
- Clinical trials of novel therapies conducted in the section's Center for Cardiometabolic Disease Prevention were presented as late-breaking clinical trials and with simultaneous publication in New England Journal of Medicine
- With 8 new grants awarded this year, section research is supported by 41 grants, including numerous NIH awards and 14 clinical trials
- The section's Lipid Metabolism and Atherosclerosis Clinic is the only clinic in the Houston area that offers comprehensive genetic testing including polygenic risk scores for cardiometabolic disorders
- Section faculty hold key positions in major professional organizations such as the American College of Cardiology, American Society for Preventive Cardiology, Heart Rhythm Society, and National Lipid Association, continuing to shape and advance the fields of cardiovascular research and preventive cardiology
Heading
Chief's Message
Content
View a message from the Section of Cardiovascular Research Chief, Christie M. Ballantyne, M.D.
Heading
Education
Content
We offer educational opportunities for medical students, predoctoral and postdoctoral students, and fellows, in both clinical and basic research areas.
Heading
Research
Content
Our section conducts basic science, clinical, and translational research focusing on mechanisms, diagnosis, treatment, and prevention of atherothrombotic cardiovascular disease and other cardiometabolic diseases.
Heading
Healthcare
Content
We offer-state-of-the-art specialized care in the Lipid Metabolism and Atherosclerosis Clinic, part of the Center for Cardiometabolic Disease Prevention.
